Aleafia Health Subsidiary Secures Regulatory Approvals for Cannabis Sales in Germany

 — Aleafia Health Inc.’s (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) indirect subsidiary, Aleafia Health Germany GmbH (“Aleafia Germany”) will commence distributing medical cannabis products to German pharmacies following regulatory approvals. Aleafia Germany has now received a controlled drug licence from the Federal Institute for Drugs and Medical Devices and a European UnionContinue reading “Aleafia Health Subsidiary Secures Regulatory Approvals for Cannabis Sales in Germany”

Aleafia Health Announces Appointment of Pharmaceutical Executive Tricia Symmes as Chief Commercial Officer

TORONTO, Aug. 21, 2020 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) today announced the appointment of Tricia Symmes as the Company’s Chief Commercial Officer, effective August 27, 2020. Symmes brings over 20 years of experience as a senior executive in the pharmaceutical, consumer packaged goods, and cannabis industries.Continue reading “Aleafia Health Announces Appointment of Pharmaceutical Executive Tricia Symmes as Chief Commercial Officer”

Aleafia Health Launches Same-Day, Direct-to-Door Medical Cannabis Delivery

— Aleafia Health Inc.’s (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) AssureHome Delivery, the industry-leading direct-to-door medical cannabis service, has now launched same-day delivery. Previously, the service offered next-day delivery only. Highlights include: Medical cannabis orders received before noon on any business day will be shipped and delivered the same day. Available toContinue reading “Aleafia Health Launches Same-Day, Direct-to-Door Medical Cannabis Delivery”

Aleafia Health Approved by Janssen Pharmaceuticals to Administer Antidepressant SPRAVATO®

SPRAVATO® (esketamine) nasal spray uses the first new mechanism of action in decades to treat treatment resistant depression disorder  Aleafia Health medical clinics along with select physicians and nurses now approved to administer and prescribe, following completion of Janssen Journey certification Offering expands Aleafia’s health and wellness solutions to existing and prospective patients across Canada SPRAVATO® approved by the U.S. Food andContinue reading “Aleafia Health Approved by Janssen Pharmaceuticals to Administer Antidepressant SPRAVATO®”

Aleafia Health Provides Update on Strategic Growth Initiatives

— Aleafia Health Inc. (TSX: AH) (OTC: ALEAF) (“Aleafia Health” or the “Company”), a global cannabis health and wellness company, is pleased to provide a corporate update on strategic growth initiatives. “Commencing the production of our first Cannabis 2.0 product formats represents a major milestone for Aleafia Health, as we scale our business,” said AleafiaContinue reading “Aleafia Health Provides Update on Strategic Growth Initiatives”

Aphria Announces Issuance of Shares in Respect of Previously Announced Settlement of Claim

– Aphria Inc. (“Aphria“) (TSX: APHA andNASDAQ: APHA), a leading global cannabis company, today announced that it has issued 1,658,375 common shares (the “Settlement Shares“) to Emblem Cannabis Corporation (“Emblem“), a wholly owned subsidiary of Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health“) as part of a settlement agreement entered into between the parties and previouslyContinue reading “Aphria Announces Issuance of Shares in Respect of Previously Announced Settlement of Claim”

Aleafia Health Announces Election of Directors

— Aleafia Health Inc. (the “Company”) (TSX: AH) (OTC: ALEAF) is pleased to announce the results of the vote on the election of directors at its annual and special meeting of shareholders held on June 30, 2020 (the “Meeting”). All six nominees set out in the management information circular of the Company dated May 20, 2020Continue reading “Aleafia Health Announces Election of Directors”

Aleafia Health Provides Corporate Update

TORONTO, May 20, 2020 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that the board of directors (the “Board”) has elected an Acting Chair and reconstituted its committees following the recent addition of Rhonda Lawson and Glenn Washer to the Board. The Board hasContinue reading “Aleafia Health Provides Corporate Update”

Aleafia Health Announces $6.4M Positive Adjusted EBITDA, $14.6M Net Revenue in Q1 2020

$13.7M cannabis net revenue, 183% increase over previous quarter, and 2,486% increase over prior year’s quarter Positive cash flow from operations 85% gross margin on cannabis net revenue 3% increase SG&A expenses over previous quarter $35M in cash, cash equivalents and marketable securities Total liabilities decline by $7.9 million over Q4 2019 Fifth consecutive quarterContinue reading “Aleafia Health Announces $6.4M Positive Adjusted EBITDA, $14.6M Net Revenue in Q1 2020”